Lyra therapeutics to report second quarter 2021 financial results on august 9

Watertown, mass., july 26, 2021 (globe newswire) -- lyra therapeutics, inc. (nasdaq: lyra), a clinical-stage therapeutics company leveraging its proprietary xtreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ent) passages and other diseased tissues, today announced the company will report second quarter 2021 financial results on monday, august 9, 2021 after the close of market. lyra will host a conference call and live webcast at 4:30 p.m. et on the same day to discuss the results and provide a business update.
LYRA Ratings Summary
LYRA Quant Ranking